Hints and tips:
Related Special Reports
Related Topics
...Pfizer’s chief executive Albert Bourla said on the company’s most recent earnings call that it would have much more clarity and certainty about the future of its Covid products by the end of the year....
...The new EU negotiations come as the European public prosecutor is investigating texts between Ursula von der Leyen, president of the European Commission, and Pfizer’s chief executive, Albert Bourla, before...
...Chief executive Albert Bourla said the company was “entering 2024 with a solid foundation”, and called the completion of the $43bn acquisition of cancer drugmaker Seagen in December, “a critical step” towards...
...Albert Bourla said people were growing “tired” of the measures introduced to slow the spread of the virus, while “politicians want to claim victory”....
...Albert Bourla, the chief executive of Pfizer, called the testimony “one of the most despicable moments in the history of US academia”....
...Pfizer paid chief executive Albert Bourla $33mn in 2022, a 35 per cent increase from a year earlier. The jump in pay came even as Pfizer shares fell 13 per cent during 2022....
...“We are acutely aware that all these uncertainties are making it difficult to project the future revenues of Pfizer — and are also affecting our stock price,” Albert Bourla, the company’s chief executive...
...Albert Bourla, Pfizer’s chief executive, said the company’s product portfolio, apart from Covid medicines, remained strong, with the company expecting revenues from the rest of the business to grow between...
...Crowding into the Hyatt Regency to meet the Chinese leader were Elon Musk of Tesla, Tim Cook of Apple and Albert Bourla of Pfizer, all keen on selling more electric cars, iPhones and pharmaceuticals in the...
...Pfizer CEO Albert Bourla will join as part of his second visit to China in two months. Bourla told the FT earlier this month he still saw “very big” opportunity for Pfizer in the country....
...The letter was organised by the Partnership for New York City, a group co-chaired by Albert Bourla, chair and chief executive of Pfizer, and Rob Speyer, president and chief executive of Tishman Speyer, the...
...Albert Bourla, Pfizer chief executive, said on Monday that a local contract manufacturer was gearing up to begin production as demand skyrockets for the oral antiviral treatment amid a supply crunch in China...
...With revenues expected to fall by a third to between $67bn to $71bn this year, chief executive Albert Bourla is under pressure to spend its huge cash pile to keep growth humming....
...Pfizer chief executive Albert Bourla said 2023 would be a transition year for the company as the Covid-19 market in the US moved from a government to a private marketplace and Pfizer prepared to launch a...
...Pfizer’s chief executive Albert Bourla said the pharma group was “deploying its financial resources to advance the battle against cancer”....
...Chief executive Albert Bourla said 2023 would be a “transition” year for the company as the Covid market in the US shifted from one where the government was the principal payer for products to a more traditional...
...Albert Bourla, the Pfizer chief executive — and grandchild of Holocaust victims — called the presidents’ testimony “one of the most despicable moments in the history of US academia”....
...Bourla....
...Instead, since becoming chief executive in 2019, Albert Bourla, has sought to transform the company from a diversified pharmaceutical conglomerate into a nimbler, science-led business....
...Pfizer’s chief executive Albert Bourla has likened this aspect of the reforms to “negotiating with a gun to your head”....
...Bourla, Pfizer chief executive....
...Pfizer chief executive Albert Bourla said the company expected more mature immune response data on the bivalent booster to be released in the coming weeks....
...“They are the second-highest economy in the world,” Pfizer chief executive Albert Bourla told a conference in San Francisco this month. “I don’t think that they should pay less than El Salvador.”...
...Albert Bourla, Pfizer chief executive, said patient usage of Paxlovid is increasing in the US but is weaker in other countries, a cause of concern among some analysts who have warned that slow uptake of...
...Bourla, Pfizer’s chief executive....
International Edition